Copyright Reports & Markets. All rights reserved.

Global Generic Active Pharmaceutical Ingredients Market Research Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Generic Active Pharmaceutical Ingredients Market Overview

      • 1.1 Product Overview and Scope of Generic Active Pharmaceutical Ingredients
      • 1.2 Generic Active Pharmaceutical Ingredients Segment by Type
        • 1.2.1 Global Generic Active Pharmaceutical Ingredients Production Growth Rate Comparison by Type (2014-2025)
        • 1.2.2 Monoclonal Antibodies
        • 1.2.3 Hormones
        • 1.2.4 Cytokines
        • 1.2.5 Fusion Proteins
        • 1.2.6 Therapeutic Enzymes
        • 1.2.7 Vaccines
        • 1.2.8 Blood Factors
      • 1.3 Generic Active Pharmaceutical Ingredients Segment by Application
        • 1.3.1 Generic Active Pharmaceutical Ingredients Consumption Comparison by Application (2014-2025)
        • 1.3.2 Oncology
        • 1.3.3 Diabetes
        • 1.3.4 Cardiovascular Disease
        • 1.3.5 CNS and Neurological Disorders
        • 1.3.6 Endocrinology
        • 1.3.7 Others
      • 1.3 Global Generic Active Pharmaceutical Ingredients Market by Region
        • 1.3.1 Global Generic Active Pharmaceutical Ingredients Market Size Region
        • 1.3.2 North America Status and Prospect (2014-2025)
        • 1.3.3 Europe Status and Prospect (2014-2025)
        • 1.3.4 China Status and Prospect (2014-2025)
        • 1.3.5 Japan Status and Prospect (2014-2025)
        • 1.3.6 Southeast Asia Status and Prospect (2014-2025)
        • 1.3.7 India Status and Prospect (2014-2025)
      • 1.4 Global Generic Active Pharmaceutical Ingredients Market Size
        • 1.4.1 Global Generic Active Pharmaceutical Ingredients Revenue (2014-2025)
        • 1.4.2 Global Generic Active Pharmaceutical Ingredients Production (2014-2025)

      2 Global Generic Active Pharmaceutical Ingredients Market Competition by Manufacturers

      • 2.1 Global Generic Active Pharmaceutical Ingredients Production Market Share by Manufacturers (2014-2019)
      • 2.2 Global Generic Active Pharmaceutical Ingredients Revenue Share by Manufacturers (2014-2019)
      • 2.3 Global Generic Active Pharmaceutical Ingredients Average Price by Manufacturers (2014-2019)
      • 2.4 Manufacturers Generic Active Pharmaceutical Ingredients Production Sites, Area Served, Product Types
      • 2.5 Generic Active Pharmaceutical Ingredients Market Competitive Situation and Trends
        • 2.5.1 Generic Active Pharmaceutical Ingredients Market Concentration Rate
        • 2.5.2 Generic Active Pharmaceutical Ingredients Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global Generic Active Pharmaceutical Ingredients Production Market Share by Regions

      • 3.1 Global Generic Active Pharmaceutical Ingredients Production Market Share by Regions
      • 3.2 Global Generic Active Pharmaceutical Ingredients Revenue Market Share by Regions (2014-2019)
      • 3.3 Global Generic Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.4 North America Generic Active Pharmaceutical Ingredients Production
        • 3.4.1 North America Generic Active Pharmaceutical Ingredients Production Growth Rate (2014-2019)
        • 3.4.2 North America Generic Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.5 Europe Generic Active Pharmaceutical Ingredients Production
        • 3.5.1 Europe Generic Active Pharmaceutical Ingredients Production Growth Rate (2014-2019)
        • 3.5.2 Europe Generic Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.6 China Generic Active Pharmaceutical Ingredients Production (2014-2019)
        • 3.6.1 China Generic Active Pharmaceutical Ingredients Production Growth Rate (2014-2019)
        • 3.6.2 China Generic Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.7 Japan Generic Active Pharmaceutical Ingredients Production (2014-2019)
        • 3.7.1 Japan Generic Active Pharmaceutical Ingredients Production Growth Rate (2014-2019)
        • 3.7.2 Japan Generic Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)

      4 Global Generic Active Pharmaceutical Ingredients Consumption by Regions

      • 4.1 Global Generic Active Pharmaceutical Ingredients Consumption by Regions
      • 4.2 North America Generic Active Pharmaceutical Ingredients Consumption (2014-2019)
      • 4.3 Europe Generic Active Pharmaceutical Ingredients Consumption (2014-2019)
      • 4.4 China Generic Active Pharmaceutical Ingredients Consumption (2014-2019)
      • 4.5 Japan Generic Active Pharmaceutical Ingredients Consumption (2014-2019)

      5 Global Generic Active Pharmaceutical Ingredients Production, Revenue, Price Trend by Type

      • 5.1 Global Generic Active Pharmaceutical Ingredients Production Market Share by Type (2014-2019)
      • 5.2 Global Generic Active Pharmaceutical Ingredients Revenue Market Share by Type (2014-2019)
      • 5.3 Global Generic Active Pharmaceutical Ingredients Price by Type (2014-2019)
      • 5.4 Global Generic Active Pharmaceutical Ingredients Production Growth by Type (2014-2019)

      6 Global Generic Active Pharmaceutical Ingredients Market Analysis by Applications

      • 6.1 Global Generic Active Pharmaceutical Ingredients Consumption Market Share by Application (2014-2019)
      • 6.2 Global Generic Active Pharmaceutical Ingredients Consumption Growth Rate by Application (2014-2019)

      7 Company Profiles and Key Figures in Generic Active Pharmaceutical Ingredients Business

      • 7.1 Pfizer, Inc. (U.S.)
        • 7.1.1 Pfizer, Inc. (U.S.) Generic Active Pharmaceutical Ingredients Production Sites and Area Served
        • 7.1.2 Generic Active Pharmaceutical Ingredients Product Introduction, Application and Specification
        • 7.1.3 Pfizer, Inc. (U.S.) Generic Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.1.4 Main Business and Markets Served
      • 7.2 Novartis International AG (Switzerland)
        • 7.2.1 Novartis International AG (Switzerland) Generic Active Pharmaceutical Ingredients Production Sites and Area Served
        • 7.2.2 Generic Active Pharmaceutical Ingredients Product Introduction, Application and Specification
        • 7.2.3 Novartis International AG (Switzerland) Generic Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.2.4 Main Business and Markets Served
      • 7.3 Sanofi (France)
        • 7.3.1 Sanofi (France) Generic Active Pharmaceutical Ingredients Production Sites and Area Served
        • 7.3.2 Generic Active Pharmaceutical Ingredients Product Introduction, Application and Specification
        • 7.3.3 Sanofi (France) Generic Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.3.4 Main Business and Markets Served
      • 7.4 Boehringer Ingelheim (Germany)
        • 7.4.1 Boehringer Ingelheim (Germany) Generic Active Pharmaceutical Ingredients Production Sites and Area Served
        • 7.4.2 Generic Active Pharmaceutical Ingredients Product Introduction, Application and Specification
        • 7.4.3 Boehringer Ingelheim (Germany) Generic Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.4.4 Main Business and Markets Served
      • 7.5 Bristol-Myers Squibb (U.S.)
        • 7.5.1 Bristol-Myers Squibb (U.S.) Generic Active Pharmaceutical Ingredients Production Sites and Area Served
        • 7.5.2 Generic Active Pharmaceutical Ingredients Product Introduction, Application and Specification
        • 7.5.3 Bristol-Myers Squibb (U.S.) Generic Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.5.4 Main Business and Markets Served
      • 7.6 Teva Pharmaceutical Industries Ltd. (Israel)
        • 7.6.1 Teva Pharmaceutical Industries Ltd. (Israel) Generic Active Pharmaceutical Ingredients Production Sites and Area Served
        • 7.6.2 Generic Active Pharmaceutical Ingredients Product Introduction, Application and Specification
        • 7.6.3 Teva Pharmaceutical Industries Ltd. (Israel) Generic Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.6.4 Main Business and Markets Served
      • 7.7 Eli Lilly and Company (U.S.)
        • 7.7.1 Eli Lilly and Company (U.S.) Generic Active Pharmaceutical Ingredients Production Sites and Area Served
        • 7.7.2 Generic Active Pharmaceutical Ingredients Product Introduction, Application and Specification
        • 7.7.3 Eli Lilly and Company (U.S.) Generic Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.7.4 Main Business and Markets Served
      • 7.8 GlaxoSmithKline plc (U.K.)
        • 7.8.1 GlaxoSmithKline plc (U.K.) Generic Active Pharmaceutical Ingredients Production Sites and Area Served
        • 7.8.2 Generic Active Pharmaceutical Ingredients Product Introduction, Application and Specification
        • 7.8.3 GlaxoSmithKline plc (U.K.) Generic Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.8.4 Main Business and Markets Served
      • 7.9 Merck & Co., Inc. (U.S.)
        • 7.9.1 Merck & Co., Inc. (U.S.) Generic Active Pharmaceutical Ingredients Production Sites and Area Served
        • 7.9.2 Generic Active Pharmaceutical Ingredients Product Introduction, Application and Specification
        • 7.9.3 Merck & Co., Inc. (U.S.) Generic Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.9.4 Main Business and Markets Served
      • 7.10 AbbVie Inc. (U.S.)
        • 7.10.1 AbbVie Inc. (U.S.) Generic Active Pharmaceutical Ingredients Production Sites and Area Served
        • 7.10.2 Generic Active Pharmaceutical Ingredients Product Introduction, Application and Specification
        • 7.10.3 AbbVie Inc. (U.S.) Generic Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.10.4 Main Business and Markets Served

      8 Generic Active Pharmaceutical Ingredients Manufacturing Cost Analysis

      • 8.1 Generic Active Pharmaceutical Ingredients Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
      • 8.3 Manufacturing Process Analysis of Generic Active Pharmaceutical Ingredients
      • 8.4 Generic Active Pharmaceutical Ingredients Industrial Chain Analysis

      9 Marketing Channel, Distributors and Customers

      • 9.1 Marketing Channel
        • 9.1.1 Direct Marketing
        • 9.1.2 Indirect Marketing
      • 9.2 Generic Active Pharmaceutical Ingredients Distributors List
      • 9.3 Generic Active Pharmaceutical Ingredients Customers

      10 Market Dynamics

      • 10.1 Market Trends
      • 10.2 Opportunities
      • 10.3 Market Drivers
      • 10.4 Challenges
      • 10.5 Influence Factors

      11 Global Generic Active Pharmaceutical Ingredients Market Forecast

      • 11.1 Global Generic Active Pharmaceutical Ingredients Production, Revenue Forecast
        • 11.1.1 Global Generic Active Pharmaceutical Ingredients Production Growth Rate Forecast (2019-2025)
        • 11.1.2 Global Generic Active Pharmaceutical Ingredients Revenue and Growth Rate Forecast (2019-2025)
        • 11.1.3 Global Generic Active Pharmaceutical Ingredients Price and Trend Forecast (2019-2025)
      • 11.2 Global Generic Active Pharmaceutical Ingredients Production Forecast by Regions (2019-2025)
        • 11.2.1 North America Generic Active Pharmaceutical Ingredients Production, Revenue Forecast (2019-2025)
        • 11.2.2 Europe Generic Active Pharmaceutical Ingredients Production, Revenue Forecast (2019-2025)
        • 11.2.3 China Generic Active Pharmaceutical Ingredients Production, Revenue Forecast (2019-2025)
        • 11.2.4 Japan Generic Active Pharmaceutical Ingredients Production, Revenue Forecast (2019-2025)
      • 11.3 Global Generic Active Pharmaceutical Ingredients Consumption Forecast by Regions (2019-2025)
        • 11.3.1 North America Generic Active Pharmaceutical Ingredients Consumption Forecast (2019-2025)
        • 11.3.2 Europe Generic Active Pharmaceutical Ingredients Consumption Forecast (2019-2025)
        • 11.3.3 China Generic Active Pharmaceutical Ingredients Consumption Forecast (2019-2025)
        • 11.3.4 Japan Generic Active Pharmaceutical Ingredients Consumption Forecast (2019-2025)
      • 11.4 Global Generic Active Pharmaceutical Ingredients Production, Revenue and Price Forecast by Type (2019-2025)
      • 11.5 Global Generic Active Pharmaceutical Ingredients Consumption Forecast by Application (2019-2025)

      12 Research Findings and Conclusion

        13 Methodology and Data Source

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        The global Generic Active Pharmaceutical Ingredients market is valued at million US$ in 2018 is expected to reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
        This report focuses on Generic Active Pharmaceutical Ingredients volume and value at global level, regional level and company level. From a global perspective, this report represents overall Generic Active Pharmaceutical Ingredients market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
        At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

        The following manufacturers are covered:
        Pfizer, Inc. (U.S.)
        Novartis International AG (Switzerland)
        Sanofi (France)
        Boehringer Ingelheim (Germany)
        Bristol-Myers Squibb (U.S.)
        Teva Pharmaceutical Industries Ltd. (Israel)
        Eli Lilly and Company (U.S.)
        GlaxoSmithKline plc (U.K.)
        Merck & Co., Inc. (U.S.)
        AbbVie Inc. (U.S.)

        Segment by Regions
        North America
        Europe
        China
        Japan

        Segment by Type
        Monoclonal Antibodies
        Hormones
        Cytokines
        Fusion Proteins
        Therapeutic Enzymes
        Vaccines
        Blood Factors

        Segment by Application
        Oncology
        Diabetes
        Cardiovascular Disease
        CNS and Neurological Disorders
        Endocrinology
        Others

        Buy now